
Key Points
- The government collected RM209.5 million(US$50.07 million) in excise duty from nicotine vape products between April 2023 and August 2025.
- Health Minister Dr Dzulkefly Ahmad reported RM223.5 million(US$53.42 million) spent on EVALI treatment in the past year.
- The average treatment cost per patient was RM150,892.11, with a 12-day hospitalisation period.
- Since the Control of Smoking Products for Public Health Act took effect on Oct 1, 2024, six severe EVALI cases have been recorded.
- From 2019 to September 2025, 46 EVALI cases were reported nationwide. The ministry will continue to strengthen control measures.
According to Finance Ministry data, Malaysia collected RM209.5 million(approximately US$50.07 million) in excise duty on nicotine-containing liquids and gels used in vapes and e-cigarettes from April 2023 to August 2025.
However, Health Minister Datuk Seri Dr Dzulkefly Ahmad said the amount is lower than the RM223.5 million(US$53.42 million) spent on treating patients suffering from e-cigarette or vaping product use-associated lung injury (EVALI) in the past year.
“The average treatment cost per EVALI patient is RM150,892.11, with an average hospitalisation period of 12 days,” he said in a written parliamentary reply to Datuk Alias Razak (PN–Kuala Nerus).
Alias had asked for the total excise duty collected on nicotine between April 2023 and September 2023, and how it compared to treatment costs for EVALI patients during the same period.
The excise duty on nicotine-containing vape liquids and gels was introduced on April 1, 2023, at a rate of 40 sen per millilitre.
Dzulkefly added that since the Control of Smoking Products for Public Health Act 2024 came into effect on Oct 1 last year, six severe EVALI-related lung complications have been reported up to September this year.
“Overall, from 2019 to September this year, the ministry has recorded 46 EVALI cases nationwide. The ministry will continue to monitor the impact of vape use on public health and strengthen control measures through full enforcement of the act,” he said.
Image Source:New Straits Times
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com








